Annual Meeting ISS: Beyond the Guidelines: Perspectives on the Role of PARP Inhibition in the Management of Ovarian Cancer
A CME Virtual Satellite Symposium in conjunction with the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer® Webinar Series.
Join Dr. Neil Love and a panel of gynecologic oncology clinical investigators as they discuss the current and future role of PARP inhibitors in the management of ovarian, cervical and endometrial cancer. This interactive webinar will include polling, case studies and panel discussions as well as questions from the audience throughout the program.
1.5 AMA PRA Category 1 Credits™
A link to the event will be provided after registration.
Robert L. Coleman, MD
Professor and Executive Director, Cancer Network Research
Ann Rife Cox Chair in Gynecology, Department of Gynecologic Oncology and Reproductive Medicine
The University of Texas MD Anderson Cancer Center, Houston, TX
Joyce F. Liu, MD, MPH
Assistant Professor of Medicine, Harvard Medical School
Director of Clinical Research, Division of Gynecologic Oncology
Dana-Farber Cancer Institute, Boston, MA
Kathleen Moore, MD
The Virginia Kerley Cade Endowed Chair in Cancer Development
Associate Director, Clinical Research
Director, Oklahoma TSET Phase I Program, Stephenson Cancer Center
Associate Professor, Section of Gynecologic Oncology
Director, Gynecologic Oncology Fellowship, Department of Obstetrics and Gynecology
University of Oklahoma Health Sciences Center, Oklahoma City, OK
Additional faculty to be announced.
Neil Love, MD
Research To Practice, Miami, FL
SGO does not offer CE for any of the Industry Sponsored Symposia. The offering of ISS does not constitute endorsement by the SGO of the information, products or services contained therein.